Researchers sought to determine predictors and prevalence of pulmonary hypertension, LVDD, and LV systolic dysfunction in patients with CKD that do not need dialysis.
Toby Maher, MD, describes the increased prevalence of lung manifestations in scleroderma and the need for routine screening among these patients.
Study investigators assessed whether cardiac axis deviation may indicate cardiac function abnormalities, allowing for predictions of disease severity and mortality.
Researchers determined the effect of increased frequency of rehabilitation on stroke risk.
Systemic anticoagulation was found to improve quality-adjusted life years among patients with idiopathic pulmonary arterial hypertension but not among those with connective tissue disease-associated pulmonary arterial hypertension.
Hyperuricemia may represent a risk factor for stroke, and severe hypertension may mediate this association.
Pulmonary arterial hypertension with systemic sclerosis associated-survival improved over time among patients aged 70 years or younger, but not among the elderly.
Researchers evaluated whether cardiopulmonary exercise testing could improve the performance of the DETECT screening approach in systemic sclerosis-related pulmonary arterial hypertension.
Researchers sought to determine the benefits of using a prognostic equation and risk score calculator to predict survival in systemic sclerosis-associated PAH.
Use of the DETECT algorithm did not change incidence of PAH, but led to an increased frequency of cases of borderline pulmonary hypertension.
